MedPath

Ethanol lock solution for the prevention of tunnelled central venous catheter infections in paediatric oncology patients A randomized controlled trial

Phase 3
Conditions
prevention of catheter related infection
10019815
Registration Number
NL-OMON29924
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
600
Inclusion Criteria

Paediatric oncology patients age 1-18 years
who will have a central venous tunneled catheter inserted (internal or external device)

Exclusion Criteria

all patients who have had a previous catheter inserted
patients with signs and symptoms of infection at time of catheter insertion
patients<1 year of age
patients with an allergy for alcohol

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>First Endpoint : All patients will be prospectively followed till time of first<br /><br>documented catheter related infection, till death, or till removal of the<br /><br>catheter, whatever endpoint will come first. Total duration of the study is<br /><br>maximal 6 months.<br /><br>Secondary endpoint: Occurrence of fever (with or without neutropenia),<br /><br>occurrence of thrombosis (clinical or subclinical), antibiotic use, days of<br /><br>hospital admission, clinical severity of the infection, outcome.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Side-effects will be registered, focussing on allergic reactions, flushing of<br /><br>the face, dizziness, warm feeling en liver enzyme raise (ASAT. ALAT)<br /><br>these reactions will be registered in the first hour after flushing the lock.</p><br>
© Copyright 2025. All Rights Reserved by MedPath